Literature DB >> 15050708

Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy.

Marton Graf1, Rita Jakus, Sandor Kantor, Gyorgy Levay, Gyorgy Bagdy.   

Abstract

Recent studies have provided evidence that activation of 5-HT1A receptors increases epileptic activity in the WAG/Rij rat model of absence epilepsy, and additional data have suggested the involvement of 5-HT7 receptors as well. Therefore, we have tested the effects of the selective 5-HT1A receptor antagonist WAY-100635 and the selective 5-HT7 receptor antagonist SB-258719 on spontaneous epileptic activity. In general, both compounds reduced epileptic activity compared to vehicle. Significant decreases were found in the number of paroxysms and the cumulative and average duration of spike-wave discharges (SWDs), although the time courses of these effects induced by the two compounds were clearly different. These results provide evidence that activation of 5-HT1A and 5-HT7 receptors plays a significant role in regulating SWD activity in this animal model of absence epilepsy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15050708     DOI: 10.1016/j.neulet.2004.01.072

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

Review 1.  Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

Authors:  Marcello Leopoldo; Enza Lacivita; Francesco Berardi; Roberto Perrone; Peter B Hedlund
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

2.  Differential adaptation of REM sleep latency, intermediate stage and theta power effects of escitalopram after chronic treatment.

Authors:  Szilvia Vas; Zita Kátai; Diána Kostyalik; Dorottya Pap; Eszter Molnár; Péter Petschner; Lajos Kalmár; György Bagdy
Journal:  J Neural Transm (Vienna)       Date:  2012-06-24       Impact factor: 3.575

Review 3.  Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives.

Authors:  Anne Matthys; Guy Haegeman; Kathleen Van Craenenbroeck; Peter Vanhoenacker
Journal:  Mol Neurobiol       Date:  2011-03-22       Impact factor: 5.590

4.  Zimelidine decreases seizure susceptibility in stressed mice.

Authors:  D Pericić; D S Strac; J Vlainić
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

5.  Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy.

Authors:  Rita Citraro; Antonio Leo; Pasquale De Fazio; Giovambattista De Sarro; Emilio Russo
Journal:  Br J Pharmacol       Date:  2015-04-10       Impact factor: 8.739

6.  Chronic escitalopram treatment caused dissociative adaptation in serotonin (5-HT) 2C receptor antagonist-induced effects in REM sleep, wake and theta wave activity.

Authors:  Diána Kostyalik; Zita Kátai; Szilvia Vas; Dorottya Pap; Péter Petschner; Eszter Molnár; István Gyertyán; Lajos Kalmár; László Tóthfalusi; Gyorgy Bagdy
Journal:  Exp Brain Res       Date:  2014-01-07       Impact factor: 1.972

Review 7.  Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists.

Authors:  E Kirilly; L Hunyady; G Bagdy
Journal:  J Neural Transm (Vienna)       Date:  2012-09-19       Impact factor: 3.575

8.  5-HT7 receptors are involved in neurogenic dural vasodilatation in an experimental model of migraine.

Authors:  Xiaojuan Wang; Yannan Fang; Jianbo Liang; Miansheng Yan; Rong Hu; Xiaoping Pan
Journal:  J Mol Neurosci       Date:  2014-03-02       Impact factor: 3.444

Review 9.  The role of different serotonin receptor subtypes in seizure susceptibility.

Authors:  Mohammad Hadi Gharedaghi; Mohammad Seyedabadi; Jean-Eric Ghia; Ahmad Reza Dehpour; Reza Rahimian
Journal:  Exp Brain Res       Date:  2013-11-14       Impact factor: 1.972

Review 10.  The 5-HT7 receptor and disorders of the nervous system: an overview.

Authors:  Peter B Hedlund
Journal:  Psychopharmacology (Berl)       Date:  2009-08-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.